Moderna shares underperformed the broader S&P 500 Index on August 6, 2025. The company is based in Cambridge, Massachusetts.
3 reports, 2 independent
Updated Jul 8
Gone quiet
Reached 2 outlets in its first 24 hours
- Reports
- 3
- Developments
- 1
- Repetition
- 67%
New informationRepeats or wire copies
AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.
What happened
Moderna shares underperformed the broader S&P 500 Index on August 6, 2025. The company is based in Cambridge, Massachusetts.
Who's involved
What this event is mainly aboutKeep exploring
The entities involved
Related events
- Moderna announced updates in Cambridge, MA, led by CEO Stéphane Bancel.
- Analysis suggests that both Moderna and Illumina stocks are currently overvalued.
- Royal Bank of Canada and Morgan Stanley provided analyst ratings for Moderna stock.
- Retailers like Target and TJX reported earnings, while Lowe's cited spending pressure, and Moderna shares gained dramatically.
- Citigroup lifted its price objective on Moderna, while CLSA raised Moderna to an outperform rating.
Coverage
Newest first; wire copies grouped- BarchartModerna Stock: Is Wall Street Bullish or Bearish? With a market cap of $10.7 billion, Moderna, Inc. (MRNA) is a biotechnology company specializing in the development of messenger RNA (mRNA) medicines
- ACCESS NewswireModerna to Report Second Quarter 2025 Financial Results on Friday, August 1, 2025 CAMBRIDGE, MA / ACCESS Newswire / July 11, 2025 / Moderna, Inc. (NASDAQ:MRNA) today announced that it will host a liv